ctDNA status after neoadjuvant therapy may also inform adjuvant therapy PHILADELPHIA – The presence of circulating tumor DNA (ctDNA)...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Ross Levine, MD, as editor-in-chief...
SAN ANTONIO – Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in...
SAN ANTONIO – A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored...
SAN ANTONIO – Real and sham acupuncture were more effective at improving breast cancer survivors’ perceived cognitive impairment compared...
SAN ANTONIO – Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative breast cancer when...
Preoperative MRI had no impact on five-year recurrence rates SAN ANTONIO – Patients with stage 1 or 2, hormone...
Omission of sentinel lymph node biopsy did not change five-year recurrence rates SAN ANTONIO – Skipping sentinel lymph node...
New model provided better prognostic information for recurrence in HR-positive, HER2-negative breast cancer than the Oncotype DX 21-gene recurrence...
SAN ANTONIO – Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they...